Study finds new blood test for heart disease risk:
This article was originally published in Clinica
Executive Summary
Levels of an enzyme in the blood could lead to a more accurate test for heart attack risk, according to a study published in The New England Journal of Medicine (October 23). Testing 604 patients for the enzyme myeloperoxidase predicted the early risk of myocardial infarction, as well as the risk of major adverse cardiac events, even when patients tested negative for Troponin T, said researchers at the Cleveland Clinic Foundation, Ohio.